Indivior Pharmaceuticals, Inc. INDV Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's long-term debt?
- Indivior Pharmaceuticals, Inc. (INDV) reported long-term debt of $486M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's long-term debt changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's long-term debt increased by 56.3% year-over-year, from $311M to $486M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's long-term debt?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's long-term debt has grown at a 10.6% compound annual growth rate (CAGR), from $237M to $290M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.